This is the list of Schedule V drugs as defined by the United States Controlled Substances Act.
The following findings are required for drugs to be placed in this schedule:
- The drug or other substance has a low potential for abuse relative to the drugs or other substances in schedule IV.
- The drug or other substance has a currently accepted medical use in treatment in the United States.
- Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in schedule IV.
The complete list of Schedule V drugs follows. The Administrative Controlled Substances Code Number for each drug is included.
| ACSCN |
Drug
|
| N/A
|
Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams
|
| N/A
|
Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams
|
| N/A
|
Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams
|
| N/A
|
Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit
|
| N/A
|
Not more than 100 milligrams of opium per 100 milliliters or per 100 grams
|
| N/A
|
Not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit |
Others
| ACSCN |
Drug
|
| 2710
|
Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide)) |
| 2779
|
Ezogabine (N-[2-amino-4-(4-fluorobenzylamino)-phenyl]-carbamic acid ethyl ester) |
| 2746
|
Lacosamide ([R]-2-acetoamido-N-benzyl-3-methoxy-propionamide) |
| 2790
|
Lasmiditan (2,4,6-Trifluoro-N-[6-[(1-methyl-4-piperidinyl)carbonyl]-2-pyridinyl]benzamide) |
| 2782
|
Pregabalin ([S]-3-(aminomethyl)-5-methylhexanoic acid) |
